Black Rock Inc. Axsome Therapeutics, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AXSM
# of Institutions
308Shares Held
40.3MCall Options Held
429KPut Options Held
615K-
Rtw Investments, LP New York, NY4.19MShares$410 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$391 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$231 Million34.46% of portfolio
-
Ra Capital Management, L.P. Boston, MA1MShares$97.8 Million1.25% of portfolio
-
Macquarie Group LTD Australia, C3995KShares$97.4 Million0.1% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.19B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...